Tatva Chintan Pharma IPO Date, Review, Price, Form & Market Lot Details

 

Tatva Chintan Pharma IPO may hit the market on 16th July 2021. The company to raise ₹450 via initial public offer that comprises ₹225 crore of fresh issue and ₹225 crore of offer for sale. Tatva Chintan Pharma Chem Limited incorporated in 1996 based in Gujarat. They are manufacturer of chestructure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. They are one of the largest manufacturer of SDAs for zeolites in India. The industries they serve are automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. They provide their products to India and overseas. The export revenues is around 75% and more for the company. They have 2 manufacturing facilities  at Ankleshwar and Dahej in Gujarat. Check out Tatva Chintan Pharma IPO details.

The few of the big names are their customer and the names are Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories.

Equity Shares outstanding prior to the Issue = 2,00,87,500 Shares
Fresh Issue of 20,77,562 Shares @1,038 = Rs.225 Crores
Offer for Sale of 25,39,242 Shares @1,038 = Rs.275 Crores
Equity Shares outstanding after the Issue = 2,21,65,062 Shares

Category-wise Break up:
Anchor: 13,85,041 Shares = 150.00 Crores
QIB: 9,23,361 Shares = 100.00 Crores
NII: 6,92,521 Shares = 75.00 Crores
RII: 16,15,881 Shares = 175.00  Crores (Lot size: 13 = 1,24,299 Forms)
Total Issue: 46,16,804 Shares = 500.00 Crores

Subscription required for 1X
RII = 1,24,299 Forms
NII = 75 Crores

Financial Information (Basis of Valuation)
The information is collated from the following documents:
RHP = Red Herring Prospectus Dated July 10, 2021 (373 pages)

EPS for FY17-18 >>> Rs.06.12 (Page #89 of DRHP)
EPS for FY18-19 >>> Rs.10.23 (Page #96 of RHP)
EPS for FY19-20 >>> Rs.18.81 (Page #96 of RHP)
EPS for FY20-21 >>> Rs.26.02 (Page #96 of RHP)

RoNW for FY17-18 >>> 20.79% (Page #90 of DRHP)
RoNW for FY18-19 >>> 25.78% (Page #97 of RHP)
RoNW for FY19-20 >>> 32.11% (Page #97 of RHP)
RoNW for FY20-21 >>> 31.49% (Page #97 of RHP)

NAV as on March 31, 2021 was Rs.82.62 (Page #97 of 7RHP)

Listed Industry Peer Group (Page #97 of DRHP):
Aarti Industries
Navin Fluorine International
Alkyl Amines Chemicals
Vinati Organics
Fine Organics Industries

Over Subscription Estimates*:
NII = 20K Crores. = 266.00X*
RII = 20 Lakh Forms = 17.00X* Application wise

In This Article

The Tatva Chintan Pharma IPO minimum market lot is 13 shares with ₹14,079 application amount. The retail investors can apply up-to 13 lots with 182 shares or ₹197,106 amount.

The Tatva Chintan Pharma IPO date is 16 July 2021 and the close date is 20 July 2021. The allotment date is 26 July 2021 and the IPO to list on 29 July 2021.

We are a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”). Our Company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second largest position globally. (Source: F&S Report) In addition, our Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. (Source: F&S Report) As a manufacturer of specialty chemicals, we focus on application of our products which form a key ingredient to our customers’ manufacturing and industrial processes. For instance, our SDA and PTC products have various applications in green chemistry, which is pertinent considering the growing focus on green and sustainable technologies. We continuously strive to improve our processes and infrastructure to help reduce our impact on the environment and have accordingly, undertaken various ‘green’ chemistry processes such as electrolysis. Considering the wide application of our products, we serve customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. Apart from our customers in India, we also export our products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK.

Our Company is promoted by Chintan Shah, Ajay Patel and Shekhar Somani, who each have over 24 years in the specialty chemicals manufacturing industry and have established strong business relationships with domestic as well as overseas customers. In addition, we are led by a well – qualified and experienced management team, which we believe has demonstrated its ability to manage and grow our operations and has substantial experience in the sectors in which we operate. We believe that the knowledge and experience of our management team provides us with a significant competitive advantage as we seek to grow our business.

Note: Check Tatva Chintan Pharma IPO allotment status on Linkintime website allotment URL. Click Here